Atazanavir-d9

CAS: 1092540-51-6

Ref. TR-A790053

Produktinformation

• Name: Atazanavir-d9
• Synonyme: trideuteriomethyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-4-phenyl-3-[[(2S)-4,4,4-trideuterio-2-(trideuteriomethoxycarbonylamino)-3,3-bis(trideuteriomethyl)butanoyl]amino]butyl]-2-[(4-pyridin-3-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate, 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-(1,1-dimethylethyl)-12-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, 1,14-Dimethyl (3S,8S,9S,12S)-3-(1,1-dimethylethyl)-12-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate

Beschreibung

Applications Atazanavir-d9 is the deuterated analog of Atazanavir (A790051), a azapeptide HIV protease inhibitor derivative. Atazanavir have been investigated as potential treatment of human immunodeficiency virus (HIV) and for anticancer purposes.
References Musial, B.L., et al.: Am. J. Health Syst. Pharm., 61, 1365 (2004), Wood, R., et al.: J. Acquir. Immune Defic. Syndr., 36, 684 (2004),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 719.95
• Formel: C₃₈H₁₅H₃₇N₆O₇
• Farbe/Form: Neat
• InChl: InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(21-25-13-10-9-11-14-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-16-18-27(19-17-26)28-15-12-20-39-22-28/h9-20,22,29-32,45H,21,23-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1/i1D3,2D3,3D3,7D3,8D3
• InChI Key: InChIKey=AXRYRYVKAWYZBR-AJMYWNKJSA-N
• SMILES: [2H]C([2H])([2H])C(C(NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H]